Performed technology analysis and diligence to inform business strategy in support of over $400M in acquisitions by pioneering synthetic biology and genetic engineering company Intrexon. Supported internal development programs for first-in-class products reviewed by FDA, USDA, EPA, and USFWS regulators. Advised C-suite executives on corporate technology strategy. Led internal, external, and open innovation functions to advance business and new product development.
Performed technology analysis and diligence to inform business strategy in support of over $400M in acquisitions by pioneering synthetic biology and genetic engineering company Intrexon. Supported internal development programs for first-in-class products reviewed by FDA, USDA, EPA, and USFWS regulators. Advised C-suite executives on corporate technology strategy. Led internal, external, and open innovation functions to advance business and new product development.